Pure Global
NCT05709236

Digital Versus Conventional Full-arch Implant Impression in Maxillary Screw- Retained Implant Prosthesis

Clinical Assessment of Maxillary Screw-retained Implant Prosthesis Fabricated From Digital Versus Conventional Full-arch Implant Impression: A Randomized Controlled Clinical Trial
Delta University for Science and Technology·ClinicalTrials.gov·device·Device trialCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Jaw, Edentulous
Drug/Device/Intervention
Maxillary screw-retained prosthesis
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Delta University for Science and Technology
Location
Mansoura, Egypt
Timeline & enrollment
Phase
N/A
Start date
Jan 05, 2020
End date
Aug 10, 2022
Enrollment
28 participants
Primary outcome

Number of events of prosthodontic complications

Summary

28 participants with edentulous maxillary arches were randomly selected and enrolled in two
 equal groups; Group I conventional impression group (CIG) and Group II Digital impression
 group (DIG). All patients were rehabilitated with maxillary screw-retained implant prosthesis
 retained by 6 implants. Prosthodontic complications and peri-implant MBL were registered at
 6,12, and 24 months (m). Data was collected and statistically analyzed.

ICD-10 classifications
Dislocation of jawMottled teethDisorder of gingiva and edentulous alveolar ridge, unspecifiedOther disorders of gingiva and edentulous alveolar ridgeOther specified disorders of gingiva and edentulous alveolar ridge
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05709236
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05709236 through Pure Global AI's free database. This phase not specified trial is sponsored by Delta University for Science and Technology and is currently Completed. The study focuses on Jaw, Edentulous. Target enrollment is 28 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.